Field Medical的新消融技术在8分钟内分离出肺静脉，且无严重副作用，显示出治疗心房颤动的前景。 Field Medical's new ablation tech isolated pulmonary veins in under 8 minutes with no serious side effects, showing promise for treating atrial fibrillation.

Field Medical在2026年国际AF研讨会上展示了其首个人体Field PULSE试验的最新数据，显示其高压脉冲场消融系统可在不到200毫秒内形成病灶，实现在短短7.7分钟内快速分离肺静脉。 Field Medical presented late-breaking data from its first-in-human Field PULSE trial at the 2026 International AF Symposium, showing its high-voltage pulsed field ablation system created lesions in under 200 milliseconds, enabling rapid pulmonary vein isolation in as little as 7.7 minutes. 该程序显示出很强的安全性,没有发生严重不良事件、肾损伤、胆固神经损伤或血解,也没有在核磁共振扫描中发现任何静默脑损伤。 The procedure demonstrated strong safety, with no serious adverse events, kidney injury, phrenic nerve damage, or hemolysis, and no silent brain lesions found in MRI scans. PVI的耐久性随着时间推移而改善,支持了该技术在治疗心脏各室的性纤维裂和其他心律不齐方面的潜力。 PVI durability improved over time, supporting the technology’s potential for treating atrial fibrillation and other arrhythmias across heart chambers.